Outcomes of etonogestrel subdermal contraceptive implants: A single center cross-sectional study

Article Figures & Data

Table 1

- Baseline characteristics of women using etonogestrel subdermal implants (N=345).

Variables	n (%)
Mean Age, mean±SD	30.7±6.3
Parity, median (IQR)	2 (3)
BMI, mean±SD (rage)	28.09±5.9
Chronic disease*	77 (22.0)
Have you ever used any contraception?	298 (86.0)
Reason for choosing ESI
High effectiveness	145 (42.0)
Long duration of use	108 (31.0)
Medical advice	66 (19.0)
Fewer side effects	37 (11.0)
Who influenced your decision to choose ESI?
Doctor`s recommendation	188 (54.0)
Advised from family or friends	99 (29.0)
Self-reading	68 (17.0)
Received counseling from the doctor before insertion	279 (83.0)
Choosing ESI for the second time	32 (9.0)
Duration of use, median (IQR)	12 (16) months

Values are presented as numbers and percentages (%), mean ± standard deviation (SD), or median and interquartile range (IQR).

ESI: etonogestrel subdermal implants, BMI: body mass index

↵^* Chronic disease: endocrine, central nervous system, cardiovascular and respiratory, genitourinary, gastrointestinal, and others.

Table 2

- Menstrual abnormality of women using etonogestrel subdermal implants (N=345).

Values are presented as numbers and percentages (%) and 95% confidence interval (CI).

Table 3

- Side effect of etonogestrel subdermal implants in users.

Side effects	n (%)
Skin changes	157 (46.0)
Rash	104/157 (30.0)
Acne	36/157 (10.0)
Generalized itching	7/157 (2.0)
Mood changes	101 (30.0)
Arm pain or numbness	64/345 (19.0)
Headache	59 (17.0)
Self-reported weight gain	42 (12.0)
Changes in bowel habit	28 (8.0)
Bothersome vaginal discharge	7 (2.0)
Migrated implant	1 (0.3)
Unintended pregnancy	2(0.6)
Multiple side effect	7 (2.0)

Values are presented as numbers and percentages (%).

Table 4

- Risk Factors for discontinuation of etonogestrel subdermal implants in users.

Factors	Discontinuation	P-values*	OR (95% CI)**
Age (years)
<40	9/35 (26.0)	<0.6
≥40	65/297 (22.0)	<0.6
Body mass index (kg/m²)
<30	46/203 (23.0)	<0.88
≥30	25/106 (25.0)	<0.88
Counseling
Yes	53/266 (20.0)	<0.02	0.48 (0.25-0.94)
No	19/54 (35.0)	<0.02	0.48 (0.25-0.94)
Arm pain or numbness
Yes	24/64 (32.0)	<0.002	2.5 (1.35-4.7)
No	50/268 (19.0)	<0.002	2.5 (1.35-4.7)
Mood changes
Yes	25/101 (25.0)	<0.56
No	49/229 (21.0)	<0.56
Menstrual abnormalities
Yes	63//294 (21.0)	<0.4	0.694 (0.3-1.59)
No	10/35 (29.0)	<0.4	0.694 (0.3-1.59)
Headache
Yes	17/59 (29.0)	<0.164
No	54/267 (20.0)	<0.164